Healthcare and life sciences are among the most heavily regulated industries and the US Securities and Exchange Commission continues to focus on healthcare and life sciences companies when it comes to disclosure and reporting requirements. If not managed carefully, the treatment and misuse of material non-public information can expose firms to significant liability and reputational risks. In this episode, Amy Greer and Carol Stubblefield join Dave Wardell to discuss best practices when managing material non-public…